Skip to main content

Table 1 Baseline characteristics of the study participants by treatment arm at the Dafra health district medical centre, Burkina Faso, 2008–2010

From: In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso

Intention to treat population mean ± standard deviation

ASAQ N = 220

AL N = 220

Total N = 440

Gender m/f, %

45.4/54.6

55.6/44.6

50.5/49.6

Age, year

6.4 ± 3.2

6.4 ± 3.1

6.5 ± 3.1

Height, cm

114.3 ± 19.4

114 ± 19.5

114.15 ± 19.4

Weight, kg

19.1 ± 7.5

18.9 ± 8.0

19.01 ± 7.7

GMPD, parasitaemia/µl

44567

47074

45803

  1. AL artemether–lumefantrine, ASAQ artesunate plus amodiaquine, GMPD geometric mean of parasite density